Skip to content

Drug interactions

Nilotinib + Temsirolimus

Severity: Moderate

Nilotinib and Temsirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Temsirolimus is converted to sirolimus, a CYP3A4 substrate, and nilotinib may raise levels of these compounds. This can increase mTOR inhibitor toxicity such as stomatitis, cytopenias and metabolic effects.

What this interaction means in plain words

Nilotinib and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Nilotinib belongs to Oncology; Temsirolimus belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 metabolism by nilotinib.

What to do

Monitor for temsirolimus toxicity and blood counts, and reduce the dose if adverse effects emerge. Monitor QTc because of nilotinib.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nilotinib and Temsirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nilotinib with Temsirolimus?

MediHelp rates the interaction as moderate. Nilotinib and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Temsirolimus is converted to sirolimus, a CYP3A4 substrate, and nilotinib may raise levels of these compounds. This can increase mTOR inhibitor toxicity such as stomatitis, cytopenias and metabolic effects.

How serious is the interaction between Nilotinib and Temsirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for temsirolimus toxicity and blood counts, and reduce the dose if adverse effects emerge. Monitor QTc because of nilotinib.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in